Journal article
Anaesthetic Management of a Patient With Immune-Mediated Necrotizing Muscle Disease With the Use of a Novel Ultrashort-Acting Benzodiazepine, Remimazolam: A Case Report
Curēus (Palo Alto, CA), Vol.15(4), e37326
04/09/2023
DOI: 10.7759/cureus.37326
PMCID: PMC10168013
PMID: 37182089
Abstract
We reported the anesthetic management of remimazolam, a novel ultra-short-acting benzodiazepine, for a 21-month-old female with immune-mediated necrotizing myopathy (IMNM). Remimazolam has a similar chemical structure to midazolam but possesses a unique side chain that reduces its propensity to accumulate in the body, thereby minimizing prolonged sedation or respiratory depression. Our experience supports that remimazolam could be a suitable agent for anesthetizing the patient with IMNM.
Details
- Title: Subtitle
- Anaesthetic Management of a Patient With Immune-Mediated Necrotizing Muscle Disease With the Use of a Novel Ultrashort-Acting Benzodiazepine, Remimazolam: A Case Report
- Creators
- Hitoshi Ogino - Kameda Medical CenterDaisuke Sugiyama - Kameda Medical CenterKenichi Ueda - Kameda Med Ctr, Anaesthesiol, Kamogawa, Japan
- Resource Type
- Journal article
- Publication Details
- Curēus (Palo Alto, CA), Vol.15(4), e37326
- DOI
- 10.7759/cureus.37326
- PMID
- 37182089
- PMCID
- PMC10168013
- NLM abbreviation
- Cureus
- ISSN
- 2168-8184
- eISSN
- 2168-8184
- Publisher
- Springer Nature
- Number of pages
- 4
- Language
- English
- Date published
- 04/09/2023
- Academic Unit
- Anesthesia
- Record Identifier
- 9984787241202771
Metrics
15 Record Views